InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-26.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Strobeck Matthew, Director. Director active across 5 companies, notably QUIDEL CORP. In total, 21 reports have been recorded. Breakdown: 7 buys · 0 sell. Total volume traded: €2.6m. History available since 12 May 2021. The latest transaction was disclosed on 13 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Strobeck Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
10,000 shares@ US$23.9586100.0% of flowCommon StockSEC:0001377832-26-000003:0
Canonical exit: 14 May 2026 (T+90)
4,929 shares0Common StockSEC:0001906324-25-000099:0
4,000 shares@ US$1.39790.2% of flowCommon StockSEC:0000905148-24-002950:0
Canonical exit: 3 Feb 2025 (T+90)
2,416 shares0Common StockSEC:0000950170-24-066008:0
52,160 sharesCommon StockSEC:0000905148-24-001615:0
100,000 sharesCommon StockSEC:0001104659-24-006678:0
Canonical exit: 22 Apr 2024 (T+90)
127,777 shares@ US$1.626.0% of flowCommon StockSEC:0000905148-23-000628:0
2,248 shares0Common StockSEC:0001209191-23-035426:0
427 shares0Common StockSEC:0001209191-23-031413:0
875 shares0Common StockSEC:0001209191-23-029932:0
869,565 shares@ US$1.1530.8% of flowCommon StockSEC:0001140361-22-042597:0
Canonical exit: 19 Feb 2023 (T+90)
6,533 sharesCommon StockSEC:0000899243-22-020490:0
6,533 sharesCommon StockSEC:0000899243-22-020410:0
1,624 shares0Common StockSEC:0001209191-22-031194:0
558,659 shares@ US$1.791.70% mcap46.4% of flowCommon StockSEC:0001567619-22-008353:0
Canonical exit: 6 Jul 2022 (T+90)
20,044 sharesCommon StockSEC:0001140361-22-012920:0
138,700 shares@ US$4.3520.3% of flowCommon StockSEC:0001567619-22-000277:0
Canonical exit: 30 Mar 2022 (T+90)
19,531 shares@ US$7.68100.0% of flowCommon StockSEC:0001628280-21-024840:0
1,040 shares0Common StockSEC:0001209191-21-032981:0
20,000 sharesCommon StockSEC:0001144204-16-080228:0
Canonical exit: 9 May 2016 (T+90)
12,500 sharesCommon StockSEC:0001179110-16-018063:0
21 of 21 declarations
About Strobeck Matthew
Strobeck Matthew is Administrateur at QuidelOrtho Corp, BIODESIX INC, Accelerate Diagnostics, Inc, QUIDEL CORP and METABOLIX, INC. The record shows 21 filings, and the sampled recent filings, from 2016-01-28 to 2026-02-13, show EUR 2626486 of buys and EUR 0 of sells, with transaction nature listed as Attribution.
